Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$1.3 - $3.58 $508 - $1,399
-391 Reduced 0.85%
45,658 $109,000
Q4 2023

Feb 13, 2024

SELL
$1.0 - $1.53 $186 - $284
-186 Reduced 0.4%
46,049 $70,000
Q3 2023

Nov 13, 2023

BUY
$1.06 - $2.33 $1,742 - $3,830
1,644 Added 3.69%
46,235 $50,000
Q2 2023

Aug 04, 2023

BUY
$2.15 - $3.49 $9,455 - $15,349
4,398 Added 10.94%
44,591 $102,000
Q1 2023

May 12, 2023

BUY
$1.99 - $2.68 $1,592 - $2,144
800 Added 2.03%
40,193 $97,000
Q4 2022

Feb 10, 2023

SELL
$1.8 - $2.56 $257 - $366
-143 Reduced 0.36%
39,393 $75,000
Q3 2022

Nov 14, 2022

BUY
$1.94 - $3.43 $10,561 - $18,672
5,444 Added 15.97%
39,536 $95,000
Q2 2022

Aug 12, 2022

SELL
$1.31 - $2.69 $871 - $1,788
-665 Reduced 1.91%
34,092 $63,000
Q1 2022

May 13, 2022

SELL
$1.95 - $3.89 $4,767 - $9,511
-2,445 Reduced 6.57%
34,757 $73,000
Q4 2021

Feb 11, 2022

BUY
$3.81 - $6.16 $179 - $289
47 Added 0.13%
37,202 $147,000
Q3 2021

Nov 12, 2021

SELL
$3.38 - $5.35 $2,984 - $4,724
-883 Reduced 2.32%
37,155 $179,000
Q2 2021

Aug 13, 2021

BUY
$4.12 - $5.87 $37,302 - $53,146
9,054 Added 31.24%
38,038 $175,000
Q1 2021

May 07, 2021

BUY
$3.45 - $9.09 $17,194 - $45,304
4,984 Added 20.77%
28,984 $170,000
Q4 2020

Feb 12, 2021

SELL
$1.05 - $3.67 $722 - $2,524
-688 Reduced 2.79%
24,000 $82,000
Q3 2020

Nov 04, 2020

SELL
$1.44 - $2.1 $809 - $1,180
-562 Reduced 2.23%
24,688 $36,000
Q2 2020

Aug 12, 2020

BUY
$1.75 - $2.3 $1,191 - $1,566
681 Added 2.77%
25,250 $50,000
Q1 2020

May 04, 2020

SELL
$1.8 - $4.28 $2,554 - $6,073
-1,419 Reduced 5.46%
24,569 $48,000
Q4 2019

Feb 05, 2020

SELL
$3.16 - $5.15 $695 - $1,133
-220 Reduced 0.84%
25,988 $108,000
Q3 2019

Nov 08, 2019

SELL
$1.2 - $6.66 $218 - $1,212
-182 Reduced 0.69%
26,208 $79,000
Q2 2019

Aug 13, 2019

SELL
$5.35 - $7.11 $6,238 - $8,290
-1,166 Reduced 4.23%
26,390 $166,000
Q1 2019

May 06, 2019

SELL
$4.36 - $7.94 $3,893 - $7,090
-893 Reduced 3.14%
27,556 $153,000
Q4 2018

Feb 13, 2019

SELL
$6.15 - $10.51 $1,353 - $2,312
-220 Reduced 0.77%
28,449 $189,000
Q3 2018

Nov 09, 2018

BUY
$10.32 - $13.06 $5,345 - $6,765
518 Added 1.84%
28,669 $306,000
Q2 2018

Aug 08, 2018

BUY
$7.8 - $13.69 $4,719 - $8,282
605 Added 2.2%
28,151 $338,000
Q1 2018

May 07, 2018

SELL
$7.86 - $11.39 $11,648 - $16,879
-1,482 Reduced 5.11%
27,546 $236,000
Q4 2017

Feb 09, 2018

BUY
$8.77 - $12.28 $1,201 - $1,682
137 Added 0.47%
29,028 $287,000
Q3 2017

Nov 09, 2017

BUY
$12.17 - $16.3 $351,603 - $470,923
28,891
28,891 $355,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.